These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2734326)

  • 21. Behavioral and neurochemical evaluation of phenylpropanolamine.
    Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue.
    Holloway FA; Michaelis RC; Huerta PL
    Life Sci; 1985 Feb; 36(8):723-30. PubMed ID: 3974408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat.
    Moya-Huff FA; Kiritsy PJ; Maher TJ
    J Pharm Sci; 1987 Feb; 76(2):114-6. PubMed ID: 3572747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of phenylpropanolamine on diet selection in rats.
    Schwartz DH; Hoebel BG
    Pharmacol Biochem Behav; 1988 Nov; 31(3):721-3. PubMed ID: 3251256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative brain levels of phenylpropanolamine and amphetamine in rats.
    Henderson MG; Fuller RW
    Res Commun Chem Pathol Pharmacol; 1992 Feb; 75(2):247-50. PubMed ID: 1570407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.
    McMahon LR; Wellman PJ
    Physiol Behav; 1996 Jan; 59(1):63-9. PubMed ID: 8848492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediation of oxidative stress in hypothalamic ghrelin-associated appetite control in rats treated with phenylpropanolamine.
    Yu CH; Chu SC; Chen PN; Hsieh YS; Kuo DY
    Genes Brain Behav; 2017 Apr; 16(4):439-448. PubMed ID: 27862969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats.
    McMahon LR; Wellman PJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):767-70. PubMed ID: 9259004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance does not develop to the suppressant effects of (-)-norpseudoephedrine on ingestive behavior in the rat.
    Nencini P; Fraioli S; Perrella D
    Pharmacol Biochem Behav; 1996 Feb; 53(2):297-301. PubMed ID: 8808135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of brown adipose tissue thermogenesis induced by congeners and isomers of phenylpropanolamine.
    Wellman PJ; Marmon MM
    Life Sci; 1985 Sep; 37(11):1023-8. PubMed ID: 4033347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diurnal variation of phenylpropanolamine anorexia in rats.
    Davies BT; Wellman PJ
    Pharmacol Biochem Behav; 1990 Sep; 37(1):201-3. PubMed ID: 2263662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1992 May; 42(1):97-100. PubMed ID: 1356275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of phenylpropanolamine infusion and withdrawal on body weight and dietary composition in male and female rats.
    Rushing PA; Winders SE; Mittleman G
    Physiol Behav; 1993 Sep; 54(3):523-30. PubMed ID: 8415947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of phenylpropanolamine on regulatory and nonregulatory ingestion in adult rats.
    Mittleman G; Rushing PA; Winders SE
    Physiol Behav; 1993 Sep; 54(3):515-21. PubMed ID: 8415946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans.
    Chait LD; Uhlenhuth EH; Johanson CE
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1665-72. PubMed ID: 3737634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergism between caffeine and dl-phenylpropanolamine on brown adipose tissue thermogenesis in the adult rat.
    Wellman PJ; Marmon MM
    Pharmacol Biochem Behav; 1985 May; 22(5):781-5. PubMed ID: 4011637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats.
    Wellman PJ; McMahon LR; Green T; Tole A
    Pharmacol Biochem Behav; 1997; 57(1-2):281-4. PubMed ID: 9164583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phenylpropanolamine on gastric retention in the adult rat.
    Wellman PJ; Arasteh K; Ruddle JL; Strickland MD
    Brain Res Bull; 1986 Jul; 17(1):127-8. PubMed ID: 3756541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.